Skip to main content

Table 2 Baseline demographic and clinic data and risk factors for AAD

From: A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol

Variable

Units or Categories where appropriate

· Age

years

· Sex

male; female

· Race

white; black; Asian; Chinese; other

· Period of recruitment

summer (May – Sept); winter (Oct-March)

· Smoking

usual number of cigarettes/day

· Alcohol

usual number of units/week

· Where admitted from

home; residential care; other hospital; other

· Admission type

emergency/unplanned; elective/ planned for procedure or investigation

· Admission diagnosis or main cause of admission

 

· Co-morbidity

hypertension; asthma; diabetes; chronic obstructive airways disease; renal disease; irritable bowel syndrome; dementia; Alzheimer’s disease; other

· Previous GI surgery

 

· Number of hospital admissions in last eight weeks

 

· Antacid treatment

antacid; H2-receptor antagonist; proton pump inhibitor

· Naso-gastric tube in-situ

 

· Duration of hospital stay prior to recruitment

days

· Indication for antibiotic treatment

 

· Antibiotic treatment: antibiotic used1

single class; 2 classes; 3 or more classes

· Antibiotic treatment: total duration

single dose; 1–6 days; 7–13  days; ≥14 days

  1. 1Antibiotics will be classified according to British National Formulary categories (http://www.bnf.org): Penicillins (sub-classified as benzylpenicillin, penicillinase resistant penicillin, broad-spectrum penicillins, anti-pseudomonas penicillins); Cephalosporins (sub-classified as 1st, 2nd and 3rd generation); Carbapenems and other beta-lactams; Tetracyclines; Aminoglycosides; Macrolides; Clindamycin; Sulphonamides and trimethoprim; Metronidazole; Quinolones; Glycopeptides; TB drugs; other.